register

News & Trends - MedTech & Diagnostics

Bariatric surgery vs. medicines: Which holds the key to long-term control of type 2 diabetes?

Health Industry Hub | February 28, 2024 |

MedTech & Diagnostics News: Weight loss surgery has emerged as a more effective solution for the long-term management of type 2 diabetes compared to medical management. The study results comes as a significant stride in the battle against type 2 diabetes, a progressive multifactorial disease affecting an estimated 10% of the global population, encompassing more than 500 million adults.

Despite the mounting body of evidence supporting the efficacy of bariatric surgery, a mere fraction of clinicians and payers currently recommend this intervention for type 2 diabetes, restricting the eligibility to individuals with a body mass index (BMI) of 35 or higher. Less than 1% of those falling within this BMI range consider or pursue surgical treatment.

This pivotal study, offering the most extensive and prolonged follow-up to date, has delved into the outcomes of individuals with type 2 diabetes and overweight/obesity who were randomly assigned to either medical/lifestyle interventions or surgical treatments. This research, encompassing 262 participants across four distinct studies, scrutinised the results a decade after the interventions took place.

At the 7-year mark, 18.2% of those who underwent bariatric surgery achieved remission compared to a mere 6.2% in the medical/lifestyle management group (P = 0.02). This trend persisted at the 12-year mark, with an even more pronounced difference – 12.7% remission in the bariatric surgery group compared to a stark absence of remission in the medical/lifestyle group (P < .001).

The advantages of bariatric surgery extended beyond remission rates, as those who underwent the surgical procedure exhibited superior blood sugar control, a reduced dependency on diabetes medications, and a higher likelihood of sustained remission compared to their counterparts attempting lifestyle management.

Furthermore, the study addressed broader diabetes care goals, including the control of blood pressure and lipids, as well as the prevention of diabetes-related complications. Although no discernible differences were noted between the groups in terms of blood pressure or LDL cholesterol, bariatric surgery demonstrated its superiority by effectively raising HDL and lowering triglycerides. This aligns with findings from previous, smaller randomised controlled trials with shorter follow-up periods.

In light of these compelling results, the researchers unequivocally conclude that bariatric surgery should be embraced as a viable and effective treatment for type 2 diabetes in individuals with obesity.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Lilly's drug cuts diabetes risk by 94%, so why is it still not on the PBS?

Lilly’s drug cuts diabetes risk by 94%, so why is it still not on the PBS?

Health Industry Hub | November 14, 2024 |

On World Diabetes Day (14 November), new data reveals that three years of treatment with a GIP/GLP-1 receptor agonist significantly […]

More


News & Trends - Biotechnology

Depaz Oration to celebrate an 'enduring' legacy in the biotech sector

Depaz Oration to celebrate an ‘enduring’ legacy in the biotech sector

Health Industry Hub | November 14, 2024 |

AusBiotech announced the establishment of the Depaz Oration, an annual keynote event that will debut at the AusBiotech Conference in […]

More


News & Trends - Pharmaceuticals

Government calls for public input on genomic-led cancer care

Government calls for public input on genomic-led cancer care

Health Industry Hub | November 14, 2024 |

The Australian Government has launched a public consultation on a draft policy framework aimed at enhancing genomics-informed cancer care nationwide. […]

More


News & Trends - MedTech & Diagnostics

Can the patient voice reduce low-value care? Australia’s first large-scale hospital initiative seeks answers

Can the patient voice reduce low-value care? Australia’s first large-scale hospital initiative seeks answers

Health Industry Hub | November 14, 2024 |

In an Australian-first, a not-for-profit private health insurer will ask hospital patients to rate not only their clinical care but […]

More


This content is copyright protected. Please subscribe to gain access.